You are viewing the site in preview mode
Skip to main content
|
Neurons
| |
Inputs
|
|---|
|
\(x_{01}\)
|
Baseline characteristics
|
Age
|
|
\(x_{02}\)
| |
Region (city/rural)
|
|
\(x_{03}\)
|
History
|
History of live birth* (frequency) (city/rural)
|
|
\(x_{04}\)
| |
History of spontaneous abortion* (frequency)
|
|
\(x_{05}\)
| |
History of therapeutic abortion* (frequency)
|
|
\(x_{06}\)
| |
History of artificial abortion* (frequency)
|
|
\(x_{07}\)
| |
Other adverse reproductive history irrelevant to SLE (frequency)
|
|
\(x_{08}\)
| |
History of caesarean (frequency)
|
|
\(x_{09}\)
| |
Other chronic disease: Diabetes/Hypertension (Y/N)
|
|
\(x_{10}\)
| |
History of SLE (years)
|
|
\(x_{11}\)
| |
Pre-gestational SLE status Remission stage (Y/N)
|
|
\(x_{12}\)
| |
Pre-gestational SLE status Active stage (Y/N)
|
|
\(x_{13}\)
| |
Pre-gestational SLE status Initial onset (Y/N)
|
|
\(x_{14}\)
|
Clinical manifestation
|
Nephritis (Y/N)
|
|
\(x_{15}\)
| |
Cutaneous lesion (Y/N)
|
|
\(x_{16}\)
| |
Hematological disorder (Y/N)
|
|
\(x_{17}\)
| |
Arthritis (Y/N)
|
|
\(x_{18}\)
| |
Serositis (Y/N)
|
|
\(x_{19}\)
|
Laboratory data
|
Anti-Ro/SSA (Positive/Negative)
|
|
\(x_{20}\)
| |
Anti-La / SSB (Positive/Negative)
|
|
\(x_{21}\)
| |
Anti-dsDNA (Positive/Negative)
|
|
\(x_{22}\)
| |
Anti-Sm (Positive/Negative)
|
|
\(x_{23}\)
| |
APL (Positive/Negative)
|
|
\(x_{24}\)
| |
C3 hypocomplementania-C3 (g/L)
|
|
\(x_{25}\)
| |
C4 hypocomplementania-C4 (g/L)
|
|
\(x_{26}\)
| |
24-hour-urinary protein level (g/L)
|
|
\(x_{27}\)
| |
ADP(\(\%\))
|
|
\(x_{28}\)
|
Treatments
|
Glucocorticoid (Y/N)
|
|
\(x_{29}\)
| |
Asprin (Y/N)
|
- *Medical terms are shown in the Method section
